Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630171 · ClinicalTrials.gov registry record · NA
VerTouch Device: A Prospective Randomized Controlled Trial
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT04630171: Completed NA study, sponsored by Northwestern University.
NCT04630171 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04630171, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.
Primary Outcome
Primary endpoint is the number of redirections of the needle
Interventions
- DEVICE Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure
- DEVICE Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure
- OTHER Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
What the finished NCT04630171 record still lists
NCT04630171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure is the first listed.
NCT04630171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04630171 about?
NCT04630171 is a clinical study titled "VerTouch Device: A Prospective Randomized Controlled Trial". This study will compare the VerTouch device to palpation and ultrasound (US) techniques used to identifying the anatomic landmarks and optimal location for neuraxial access. This trial of the VerTouch device will be compared to the gold standard of palpation and the commonly cited US techniques.
What is the current status of trial NCT04630171?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2021-01-01. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT04630171?
The interventions under investigation include: Group #1: VerTouch utilized for identification of site for labor epidural or spinal anesthesia procedure (DEVICE), Group #2: Ultrasound (US) utilized for identification of site for labor epidural or spinal anesthesia procedure (DEVICE), Group #3: Control group, palpation utilized for identification of site for labor epidural or spinal anesthesia procedure (OTHER).
Who is sponsoring clinical trial NCT04630171?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04630171's enrollment target sits among peer trials
86 976th of 2000 higher than 1,021 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI